Buy Cagrilintide 10 mg by Dragon Pharma at Best Anabolic Steroids. The box contains 10 mg of lyophilised cagrilintide, a long-acting amylin analogue injected once a week in the research protocols and studied both on its own and alongside semaglutide. It is an unapproved research peptide with no ATC code. This page sets out what the amylin pathway does, how the weekly interval follows from a half-life of roughly seven days, the trial figures for weight change, the titration method, the partners used with it in the same catalogue, and the storage rules for a mixed vial.
Product Overview
Cagrilintide is a synthetic analogue of amylin, a hormone released alongside insulin after a meal, and it acts on amylin receptors rather than on the GLP-1 receptor. It is also written as GLXC-26801, and in combination with semaglutide the pair is studied under the name CagriSema.
What arrives is a 10 mg lyophilised vial that has to be reconstituted with bacteriostatic water. Ten milligrams is a large amount for a peptide dosed in micrograms to milligrams, so the reconstitution arithmetic decides how long the vial lasts and how wide the titration steps can be.
Two status facts belong here. No regulator has approved cagrilintide and no ATC code has been assigned to it, which is the formal way of saying it remains investigational. And it is not a hormone replacement: the amylin axis is not the HPTA, so nothing about this vial requires a recovery protocol.
Mechanism of Action
Amylin signalling slows the emptying of the stomach and produces satiety, which is a different mechanism from the incretin effect of a GLP-1 agonist. That difference is why the two classes are combined in research: one compound slows delivery of food from the stomach while the other changes the incretin response, and the axes are largely separate.
The pharmacokinetics support a weekly injection. In phase 1b work, cagrilintide showed a half-life of 159-195 hours, close to seven days, with peak concentrations 24-72 hours after the dose. Semaglutide measured 145-165 hours in the same study, which is why the two are paired on the same schedule.
A consequence of that long half-life is accumulation. A compound that clears over a week keeps building for a while when it is given every week, so a dose that felt manageable in week one is a larger effective exposure by week four. The titration rules below exist for that reason, not as a formality.
What to Expect on a Weekly Amylin Analogue
- Days one and two. Appetite drops and a sense of fullness appear quickly, because gastric emptying slows almost immediately after the injection.
- Weeks one and two. Nausea and smaller portions are the usual early reports from this class; the two often arrive together.
- Weeks two to eight. Body weight falls gradually while food intake stays the same, which is the pattern described in the trial material.
- Weeks eight to twenty. Most of the loss happens over the long stretch: in the phase 2 study, about 31.6 percent of participants lost at least 15 percent of body weight against about 4.7 percent on placebo.
- Sufficiently full. Appetite suppression deep enough to skip meals entirely is a dose-related finding rather than a target to aim at.
- After the last dose. Appetite returns and weight partly comes back, which is the general behaviour of this class rather than a failure of the vial.
- The limit. The compound is not approved and the long-term safety picture is thin; the figures above come from short trials.
Amounts, Titration Steps and the 10 mg Vial
No approved dose exists. The numbers below are the amounts used in published research, not a protocol written for this vial, and the weekly interval is the one the half-life supports.
| Interval | One subcutaneous injection a week, as used in the phase 2 work published in 2021 |
| Studied range | 0.16-4.5 mg in phase 1b; the co-administration arm of phase 2 used 2.4 mg of cagrilintide with 2.4 mg of semaglutide |
| Titration | Step up only after the current step is tolerated for several weeks, because exposure keeps building between doses |
| Female | The trial data are not broken down into a separate female protocol here; the same research amounts are all that is recorded |
| Reconstitution | Bacteriostatic water into the 10 mg cake; the concentration you create sets what each unit of a U-100 syringe delivers |
Two arithmetic points are worth pinning down before the first injection. Two millilitres of water across the 10 mg cake puts the mix at 5 mg per ml, so a 500 mcg step is 10 units on the scale and a 1 mg step is 20. Half that volume of water doubles every one of the figures. Because a weekly protocol runs for months, most readers choose the weaker concentration so that small titration steps remain measurable, and use a fresh vial rather than a stronger one to avoid running out mid-block.
Combining It with Incretin Peptides in the Same Catalogue
The reason cagrilintide is bought by this audience is the CagriSema idea: an amylin analogue plus a GLP-1 agonist, each on a weekly schedule, acting on two different pathways. Every partner below is a Dragon Pharma product from the same shelf.
The diluent for every one of these vials is the same bacteriostatic water, and the higher-strength Tirze Pep 10 mg vial follows the same reconstitution logic at twice the powder.
Coming Off It: Tapering Instead of PCT
Post-cycle therapy on this site exists for compounds that shut down natural testosterone production. An amylin analogue does not touch the HPTA, so a SERM block is meaningless here and the sensible exit is a step-down in dose with a break between blocks.
Nothing in the sources used for this page defines a standard taper, so the honest position is that the step-down is a precaution rather than a documented protocol.
Side Effects and the Limits of the Research
Most of the list below is a class effect of slowing gastric emptying, and most of it is dose related and manageable through titration.
Mixing the Powder and Keeping It Cold
Store the sealed vial at refrigerator temperature, between 2 and 8 degrees Celsius, in its box, and let it come to room temperature before mixing. Wipe the stopper with an alcohol swab, add the bacteriostatic water down the wall of the vial, and swirl gently until the cake is fully dissolved and the liquid is clear. Shaking a peptide is never the shortcut.
After mixing, the solution goes back into the cold at 2-8 C and is treated as usable for roughly 28 days, the working rule for a preserved multi-dose vial. Do not freeze it. Mark the mixing date on the label, draw with a fresh needle each time, and discard the vial if the solution becomes cloudy, changes colour or contains particles. Keep the vial away from sunlight and out of reach of children, and dispose of used needles in a sharps container.
Buying Cagrilintide Online
This is the amylin side of the incretin story in a single vial, and it is the right purchase for a reader who wants to work with the mechanism that the CagriSema studies are built on rather than with a GLP-1 alone. The 10 mg fill supports a long weekly titration at 500 mcg per 10 units, the page above gives the trial figures and the accumulation rule that governs how fast a step can be raised, and the storage and reconstitution rules are written out so a mixed vial is never left undated in the refrigerator. Order it here together with the incretin peptides and the bacteriostatic water from the same brand.
